NCT00263666 - A Study of Safety, Reactogenicity and Immunogenicity of HRV Vaccine in HIV Infected Infants in South Africa | Biotech Hunter

Enrollment

100

Participants

Timeline

Start Date

March 16, 2005

Primary Completion Date

February 7, 2008

Study Completion Date

February 13, 2008

Conditions

Infections, Rotavirus

Interventions

BIOLOGICAL

Rotarix

Oral vaccination

BIOLOGICAL

Placebo

Oral administration

BIOLOGICAL

Tritanrix-HB+Hib

Concomitant routine vaccination, IM administration

BIOLOGICAL

Polio Sabin

Oral administration, concomitant routine vaccination

Trial Locations (6)

GSK Investigational Site, Coronationville

GSK Investigational Site, Attridgerville

GSK Investigational Site, Garankuwa

GSK Investigational Site, Brits

GSK Investigational Site, Capital Park

GSK Investigational Site, Ga-Rankuwa